The deletion of the region containing the disease-causing variant in the OTC gene efficiently reversed the OTCD phenotype in vitro and in vivo, and editing procedures significantly improved OTC enzyme activity, with no other obvious morphological or pathological changes or major alterations in the expression of the 31 mature liver genes examined. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.